This federal contract award, valued at $3,558.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a prescription medication, over a performance period ending on April 9, 2025. The contract is a firm-fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award, valued at $1,115.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4.5 mg Vraylar capsules, a prescription medication, with a performance period through April 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,583.98, is for the delivery of Vraylar 4.5 mg capsules. It is a firm fixed-price delivery order contract with a completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $22,390.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Vraylar 1.5 mg capsules, a medication used to treat various mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,679.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,923,991 units of the prescription medication Vraylar 1.5 mg capsules. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price arrangement. The award is not designated as a set-aside contract, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,702.57, is a delivery order for 4,567,999,252 units of the prescription medication Vraylar 1.5 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,832.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has a firm fixed price and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $6,842.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Vraylar 1.5 mg capsules and is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,220.74 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a neurological medication. The contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,198.60 firm fixed-price delivery order is for the supply of 4566132500 Vraylar 1.5 mg capsules. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...